NDC 50090-5139 Ozempic
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 50090 - A-s Medication Solutions
- 50090-5139 - Ozempic
Product Packages
NDC Code 50090-5139-0
Package Description: 2 SYRINGE, PLASTIC in 1 CARTON / 1.5 mL in 1 SYRINGE, PLASTIC
Product Details
What is NDC 50090-5139?
What are the uses for Ozempic?
Which are Ozempic UNII Codes?
The UNII codes for the active ingredients in this product are:
- SEMAGLUTIDE (UNII: 53AXN4NNHX)
- SEMAGLUTIDE (UNII: 53AXN4NNHX) (Active Moiety)
Which are Ozempic Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: 94255I6E2T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PHENOL (UNII: 339NCG44TV)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Ozempic?
- RxCUI: 1991316 - semaglutide 2 MG in 1.5 ML Pen Injector, 1 MG Dose
- RxCUI: 1991316 - 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector
- RxCUI: 1991316 - semaglutide 2 MG per 1.5 ML Pen Injector, 1 MG Dose
- RxCUI: 1991317 - OZEMPIC 2 MG in 1.5 ML Pen Injector, 1 MG Dose
- RxCUI: 1991317 - 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic]
* Please review the disclaimer below.
Patient Education
Semaglutide Injection
Semaglutide injection (Ozempic) is used along with a diet and exercise program to control blood sugar levels in adults with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) when other medications did not control the sugar levels well enough. Semaglutide injection (Ozempic) is also used to reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes along with heart and blood vessel disease. It is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Semaglutide injection is not used instead of insulin to treat people with diabetes who need insulin. Semaglutide injection (Wegovy) is used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in obese adults or overweight adults who may also have high blood pressure, diabetes, or high cholesterol. Semaglutide injection (Wegovy) is also used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in obese children 12 years of age or older. Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. Semaglutide injection also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".